GB2206352B - Polypeptides - Google Patents

Polypeptides

Info

Publication number
GB2206352B
GB2206352B GB8815257A GB8815257A GB2206352B GB 2206352 B GB2206352 B GB 2206352B GB 8815257 A GB8815257 A GB 8815257A GB 8815257 A GB8815257 A GB 8815257A GB 2206352 B GB2206352 B GB 2206352B
Authority
GB
United Kingdom
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8815257A
Other versions
GB2206352A (en
GB8815257D0 (en
Inventor
Rainer Albert
Wilfried Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8815257D0 publication Critical patent/GB8815257D0/en
Publication of GB2206352A publication Critical patent/GB2206352A/en
Application granted granted Critical
Publication of GB2206352B publication Critical patent/GB2206352B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GB8815257A 1987-06-29 1988-06-27 Polypeptides Expired - Lifetime GB2206352B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721407 1987-06-29
DE3721406 1987-06-29

Publications (3)

Publication Number Publication Date
GB8815257D0 GB8815257D0 (en) 1988-08-03
GB2206352A GB2206352A (en) 1989-01-05
GB2206352B true GB2206352B (en) 1990-10-31

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8815257A Expired - Lifetime GB2206352B (en) 1987-06-29 1988-06-27 Polypeptides

Country Status (15)

Country Link
JP (1) JPS6426599A (en)
KR (1) KR890000520A (en)
AU (1) AU1840988A (en)
BE (1) BE1002663A4 (en)
CH (1) CH679045A5 (en)
DK (1) DK353788A (en)
ES (1) ES2010283A6 (en)
FR (1) FR2617171B1 (en)
GB (1) GB2206352B (en)
IL (1) IL86876A0 (en)
IT (1) IT1221065B (en)
LU (1) LU87262A1 (en)
NL (1) NL8801640A (en)
NZ (1) NZ225188A (en)
SE (1) SE8802413L (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
KR0173119B1 (en) * 1989-04-26 1999-02-01 닐 에이. 밴스로우 Linear somatostatin analog
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
WO2002010215A1 (en) * 2000-07-31 2002-02-07 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
WO2002072602A2 (en) 2001-03-08 2002-09-19 The Administrators Of The Tulane Educational Fund Somatostatin antagonists
JP2004531520A (en) * 2001-04-09 2004-10-14 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド Somatostatin agonist
KR100432178B1 (en) * 2002-01-29 2004-05-22 홍수천 Apparatus for purifying water capable of preventing corrosion of iron-based pipeline
KR100462968B1 (en) * 2002-06-10 2004-12-23 주식회사 리독스 Water treatment apparatus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (en) * 1984-03-26 1985-10-14 Techland S A NOVEL SOMATOSTATIN COMPOUNDS, PROCESS FOR THEIR SYNTHESIS, PREPARATION FOR VETERINARY USE CONTAINING SAID COMPOUNDS AND PROCESS FOR THE TREATMENT OF ANIMALS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives

Also Published As

Publication number Publication date
SE8802413D0 (en) 1988-06-28
KR890000520A (en) 1989-03-15
JPS6426599A (en) 1989-01-27
AU1840988A (en) 1989-01-05
FR2617171B1 (en) 1994-10-14
GB2206352A (en) 1989-01-05
IL86876A0 (en) 1988-11-30
LU87262A1 (en) 1989-03-08
SE8802413L (en) 1988-12-30
NL8801640A (en) 1989-01-16
FR2617171A1 (en) 1988-12-30
DK353788D0 (en) 1988-06-27
GB8815257D0 (en) 1988-08-03
ES2010283A6 (en) 1989-11-01
IT8848133A0 (en) 1988-06-28
CH679045A5 (en) 1991-12-13
BE1002663A4 (en) 1991-04-30
NZ225188A (en) 1991-04-26
IT1221065B (en) 1990-06-21
DK353788A (en) 1988-12-30

Similar Documents

Publication Publication Date Title
IL86700A0 (en) Polypeptides
EP0315367A3 (en) Polypeptides
GB2206352B (en) Polypeptides
GB8714802D0 (en) Synthetic polypeptides
GB8626622D0 (en) Polypeptides
GB8725598D0 (en) Polypeptides
ZA884655B (en) Polypeptides
IE872995L (en) Polypeptide
IE860720L (en) Polypeptides
IE862882L (en) Polypeptides
GB8700813D0 (en) Synthetic polypeptides
GB8700814D0 (en) Synthetic polypeptides
GB8700815D0 (en) Synthetic polypeptides
GB8700816D0 (en) Synthetic polypeptides
GB8700817D0 (en) Synthetic polypeptides
GB8700818D0 (en) Synthetic polypeptides
GB8716790D0 (en) Synthetic polypeptides
GB8716785D0 (en) Synthetic polypeptides
GB8716786D0 (en) Synthetic polypeptides
GB8716787D0 (en) Synthetic polypeptides
GB8716788D0 (en) Synthetic polypeptides
GB8716789D0 (en) Synthetic polypeptides
IE883303L (en) Polypeptides
IE881947L (en) Polypeptides
IE883022L (en) Polypeptides

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960627